L. USE OF L. REUTERI FOR RECOVERY OF MICROBIOTA DYSBIOSIS IN EARLY LIFE

摘要

The present invention relates to Lactobacillus luteri used for the prevention of the total microbial imbalance in young mammals, in particular the prevention or treatment of reduced levels of actinobacteria and increased levels of proteobacteria and disorders associated therewith. Total microbial imbalance may have been caused by a number of factors including births due to cesarean section, intrauterine or postnatal antibiotic exposure, or by parenteral nutrition, hospitalization, psychological stress or gastrointestinal dysfunction. Disorders that can be treated or prevented by preventing or treating microbial total imbalance include but are not limited to infections, allergies, type I diabetes mellitus, insulin resistance, type 2 diabetes, celiac disease, peripheral and central hyperplasia, obesity, necrotizing enterocolitis, Diarrheal diseases, such as Crohn's disease and ulcerative colitis, and functional gastrointestinal disorders such as IBS, functional diarrhea, functional constipation, recurrent abdominal pain and indigestion.